Shares of several stem-cell research companies jump following news that Swedish doctors replaced...

|By:, SA News Editor

Shares of several stem-cell research companies jump following news that Swedish doctors replaced the cancer-stricken windpipe of a patient with an organ made in a lab: StemCells (STEM +19.9%), Geron (GERN +8.6%), Pluristem (PSTI +4.3%), Mesoblast (MBLTY.PK +3.6%), Cytori (CYTX +2.7%).